Apatinib as Salvage Therapy for Heavily Pretreated SCLC
Small cell lung cancer (SCLC) was highly malignant and lack effective treatment after the failure of radiotherapy and chemotherapy. Antiangiogenic therapy had shown a certain effect in advanced SCLC. Apatinib, a new potent oral small-molecule tyrosine kinase inhibitor targeting the intracellular dom...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Chinês |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2018-07-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.11 |
| Tags: |
No Tags, Be the first to tag this record!
|